Your session is about to expire
← Back to Search
BNT162b2 (Omi XBB.1.5) and RIV for Coronavirus
Study Summary
This trial is testing whether it is safe and effective to combine the COVID-19 vaccine and the flu vaccine into one shot. The goal is to see if this combination can help the body produce antibodies to
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the aforementioned medical research being conducted in a substantial number of healthcare facilities across the United States?
"Several medical research facilities, including Diablo Clinical Research, Inc. in Walnut Creek, Orange County Research Center in Tustin, and GW Medical Faculty Associates in Washington D.C., are currently enrolling patients for this trial. In addition to these three locations, there are 17 other sites where patients can participate as well."
Are there any available vacancies for potential participants in this research study?
"According to the latest information available on clinicaltrials.gov, this particular study is not currently enrolling participants. Although it was initially posted on January 31st, 2024 and last updated on January 30th, 2024, patient recruitment is not ongoing at present. However, there are a substantial number of other trials—specifically, 645—that are actively seeking patients for enrollment."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger